Directory of guidance on prevention and control of Carbapenem-resistant Enterobacteriaceae, published by ECDC, EU/EEA Member States, international and national agencies and professional societies
In 2016–2017, the European Centre for Disease Prevention and Control (ECDC) organised the third point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in European long-term care facilities (LTCFs) or HALT-3.
For 2020, 2 377 malaria cases were reported in the EU/EEA, 2 369 (> 99%) of which were confirmed. Among 2 088 cases with known importation status, 99.8% were travel-related. Five confirmed cases were reported as acquired in the EU (three by France and two by Greece).
More than 35 000 people die from antimicrobial-resistant infections in the EU/EEA each year, according to estimates presented in a new report released today. The estimated number of deaths in the report examines the years 2016-2020 and shows an increase from previous estimates. The health impact of antimicrobial resistance (AMR) is comparable to that of influenza, tuberculosis and HIV/AIDS combined.